![]() |
Dr. Mobley received his Ph.D. at the University of Louisville School of Medicine and conducted postdoctoral work at the University of Maryland School of Medicine in Biochemistry and Vaccine Development, after which he joined the faculty in the Division of Infectious Diseases and rose to the rank of Professor of Microbiology and Immunology. After 23 years at Maryland, Dr. Mobley was named Chair of the Department of Microbiology and Immunology at the University of Michigan Medical School in 2004, serving in this role until 2019. Dr. Mobley’s research focuses on uropathogenic E. coli and Proteus mirabilis, but has also studied Helicobacter pylori and Gram-negative bacterial species causing bacteremia including E. coli, Klebsiella pneumoniae, Acinetobacter baumannii, Citrobacter freundii, and Serratia marcescens.
Harry L.T. Mobley | |
---|---|
Born | Harry Lee Thompson Mobley July 17, 1953 Rock Hill, South Carolina |
Nationality (legal) | American |
Alma mater | Emory University |
Awards | 2002 Elected Fellow, American Academy of Microbiology 2004 Outstanding Mentor Award, University of Maryland, Baltimore 2004-2019 Frederick G. Novy Collegiate Professorship and Chair, University of Michigan Medical School 2010-11 President, Association of Medical School Microbiology and Immunology Chairs 2011 Candidate for President-Elect, American Society for Microbiology 2012 Recipient, University of Michigan Postdoctoral Association Excellence in Mentorship Faculty Award 2012 Inductee, Atherton High School Alumni Association Hall of Fame, Louisville, Kentucky 2012 Elected Fellow, American Association for the Advancement of Science (AAAS) 2014 Named Frederick G. Novy Distinguished University Professor by the Regents of the University of Michigan 2017 Named American Society for Microbiology Distinguished Lecturer 2019 Named Frederick G. Novy Distinguished University Professor (endowed chair) |
Scientific career | |
Fields | microbiology |
Institutions | University of Michigan Medical School |
Doctoral advisor | Ronald J. Doyle |
Harry L.T. Mobley is an American microbiologist and Frederick G. Novy Distinguished University Professor of Microbiology and Immunology at the University of Michigan. [1]
Publications. Dr. Mobley has published more that 285 scientific research articles and 50 book chapters. His publications have been cited over 38,000 times.
Stanley Alan Plotkin is an American physician who works as a consultant to vaccine manufacturers, such as Sanofi Pasteur, as well as biotechnology firms, non-profits and governments. In the 1960s, he played a pivotal role in discovery of a vaccine against rubella virus while working at Wistar Institute in Philadelphia. Plotkin was a member of Wistar’s active research faculty from 1960 to 1991. Today, in addition to his emeritus appointment at Wistar, he is emeritus professor of Pediatrics at the University of Pennsylvania. His book, Vaccines, is the standard reference on the subject. He is an editor with Clinical and Vaccine Immunology, which is published by the American Society for Microbiology in Washington, D.C.
Stanley "Stan" Falkow was an American microbiologist and a professor of microbiology at Georgetown University, University of Washington, and Stanford University School of Medicine. Falkow is known as the father of the field of molecular microbial pathogenesis. He formulated molecular Koch's postulates, which have guided the study of the microbial determinants of infectious diseases since the late 1980s. Falkow spent over 50 years uncovering molecular mechanisms of how bacteria cause disease and how to disarm them. Falkow also was one of the first scientists to investigate antimicrobial resistance, and presented his research extensively to scientific, government, and lay audiences explaining the spread of resistance from one organism to another, now known as horizontal gene transfer, and the implications of this phenomenon on our ability to combat infections in the future.
Stefan Ślopek (1 December 1914 in Skawa near Kraków – 22 August 1995, Wrocław was a Polish scientist specializing in clinical microbiology and immunology.
Diane Edmund Griffin is the university distinguished professor and a professor in the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health, where she was the department chair from 1994-2015. She is also the current vice-president of the National Academy of Sciences. She holds joint appointments in the departments of Neurology and Medicine. In 2004, Griffin was elected to the United States National Academy of Sciences (NAS) in the discipline of microbial biology.
John E. Niederhuber was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.
Hugh O'Neill McDevitt ForMemRS was an immunologist and Professor of Microbiology and Immunology at Stanford University School of Medicine.
Dr. Manfred E. Bayer was a medical doctor and a microscopist, best known for his research in bacterial and viral infrastructure using electron microscopy. He was the first person to visualize yellow fever virus in cultured cells and to obtain ultra-thin sections of the cell wall of E. coli by penicillin.
Almyra Oveta Fuller was an associate professor of microbiology and immunology at University of Michigan Medical School. She served as the director of the African Studies Center (ASC), faculty in the ASC STEM Initiative at the University of Michigan (U-M) and an adjunct professor at Payne Theological Seminary. Fuller was a virologist and specialized in research of Herpes simplex virus, as well as HIV/AIDS. Fuller and her research team discovered a B5 receptor, advancing the understanding of Herpes simplex virus and the cells it attacks.
Dr. Paul B. Rothman is the former Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty, vice president for medicine at Johns Hopkins University, and former chief executive officer of Johns Hopkins Medicine. As dean and CEO, Dr. Rothman oversaw both the School of Medicine and the Johns Hopkins Health System, which together encompass six hospitals, hundreds of faculty and community physicians and a self-funded health plan.
Wolfgang Karl "Bill" Joklik was a virologist and James B. Duke Professor Emeritus of Molecular Genetics and Microbiology at Duke University, from which he retired in 1993 after 25 years chairing the department. In 1981, he founded the American Society for Virology, the first scientific society specifically for virologists, and served a two-year term as its founding president. In the same year, he was elected to the United States National Academy of Sciences. He has been described as "one of the earliest molecular virologists" and is best known for his research on poxviruses and reoviruses, and for work on interferon proteins.
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
B. Brett Finlay, is a Canadian microbiologist well known for his contributions to understanding how microbes cause disease in people and developing new tools for fighting infections, as well as the role the microbiota plays in human health and disease. Science.ca describes him as one of the world's foremost experts on the molecular understanding of the ways bacteria infect their hosts. He also led the SARS Accelerated Vaccine Initiative (SAVI) and developed vaccines to SARS and a bovine vaccine to E. coli O157:H7. His current research interests focus on pathogenic E. coli and Salmonella pathogenicity, and the role of the microbiota in infections, asthma, and malnutrition. He is currently the UBC Peter Wall Distinguished Professor and a Professor in the Michael Smith Laboratories, Microbiology and Immunology, and Biochemistry and Molecular Biology, and Co-director and Senior Fellow for the CIFAR Humans and Microbes program. He is also co-author of the book Let Them Eat Dirt: Saving Your Child from an Oversanitized World and The Whole-Body Microbiome: How to Harness Microbes - Inside and Out - For Lifelong Health. Finlay is the author of over 500 publications in peer-reviewed journals and served as editor of several professional publications for many years.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Frederick C. Neidhardt (1931-2016) was an American microbiologist who was on the faculty at Purdue University and the University of Michigan. He is known for his work on the physiology and biochemistry of bacterial growth and for early work in bacterial proteomics.
Patricia Charache was a physician specializing in infectious disease and microbiology. She was a faculty member at the Johns Hopkins University School of Medicine for more than 50 years, retiring as a Distinguished Professor Emeritus of Pathology, Medicine, and Oncology.
Noel R. Rose, was an American immunologist, pathologist, and molecular microbiologist. He is widely known for pioneering autoimmunity during the 1950s and made several contributions to the field of autoimmunity, which brought in the modern era of research into autoimmune disease. He is often referred to as the "Father of Autoimmunity".
Iruka Okeke is a Nigerian pharmaceutical microbiologist currently holding the position of professor at the College of Medicine,University of Ibadan in Nigeria. Iruka's career is the study neglected enteric bacteria such as E. coli, known for their potential to cause fatal bloodstream and diarrheal infections. She advocates for the utilization of Genomics approaches to enhance surveillance and gain a better understanding of pathogen virulence. Iruka's research interests extend to combating antimicrobial resistance and investigating bacterial pathogenesis, epidemiology, and antimicrobial resistance of enteric bacteria. Iruka's contributions to the field have earned her recognition as a fellow of esteemed institutions such as the Nigerian Academy of Sciences, and African Academy of Sciences.[1]
Robert Regier Rich is professor of medicine, microbiology and medical education, and dean emeritus at the University of Alabama School of Medicine. He served as the editor-in-chief of the Journal of Immunology from 2003 to 2008, and was elected a Fellow of AAI in 2019.
Edward John Wherry III is an American immunologist. He is the Richard and Barbara Schiffrin President's Distinguished Professor and department chair of Systems Pharmacology and Translational Therapeutics at the University of Pennsylvania. He is also the director of the Penn Institute for Immunology.
Paul Fiset was a Canadian-American microbiologist and virologist. His research helped to develop one of the first successful Q fever vaccines, noted by The New York Times. Fiset was born in Quebec, Canada, and attended Laval University, where he earned a Doctor of Medicine degree in 1949. He subsequently attended Cambridge University, where he received a PhD degree in 1956. As a professor at the University of Maryland School of Medicine, he also researched other bacterial diseases such as typhus and Rocky Mountain spotted fever, in addition to Q fever.